Details

Autor(en) / Beteiligte

• Coleman, R.
• Hadji, P.
• Body, J.-J.
• Santini, D.
• Chow, E.
• Terpos, E.
• Oudard, S.
• Bruland, Ø.
• Flamen, P.
• Kurth, A.
• Van Poznak, C.
• Aapro, M.
• Jordan, K.

Titel

Bone health in cancer: ESMO Clinical Practice Guidelines

Ist Teil von

• Annals of oncology, 2020-12, Vol.31 (12), p.1650-1663

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• •The clinical course of advanced cancer for many patients with bone metastases can be transformed through optimum multidisciplinary management.•Bone-targeted agents significantly reduce skeletal morbidity in patients with bone metastases across tumour types and should be part of standard treatment.•Treatment-induced bone loss increases fracture risk and may require use of a bone-targeted agent in addition to lifestyle modifications.•The addition of a bisphosphonate to standard adjuvant therapies for postmenopausal early breast cancer reduces bone recurrence and improves survival.